APA (7th ed.) Citation

Malaguarnera, G., Be, Chisari, G., Motta, M., Vecchio, M., Vacante, M., . . . Malaguarnera, M. (2016). Silybin supplementation during HCV therapy with pegylated interferon-[alpha] plus ribavirin reduces depression and anxiety and increases work ability. BMC psychiatry, 16(1), . https://doi.org/10.1186/s12888-016-1115-z

Chicago Style (17th ed.) Citation

Malaguarnera, Giulia, et al. "Silybin Supplementation During HCV Therapy with Pegylated Interferon-[alpha] Plus Ribavirin Reduces Depression and Anxiety and Increases Work Ability." BMC Psychiatry 16, no. 1 (2016). https://doi.org/10.1186/s12888-016-1115-z.

MLA (9th ed.) Citation

Malaguarnera, Giulia, et al. "Silybin Supplementation During HCV Therapy with Pegylated Interferon-[alpha] Plus Ribavirin Reduces Depression and Anxiety and Increases Work Ability." BMC Psychiatry, vol. 16, no. 1, 2016, https://doi.org/10.1186/s12888-016-1115-z.